ArticleJournal of Cancer2026

Neoadjuvant Pembrolizumab Combined with Chemotherapy for Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinomas: A Single-center Retrospective Study.

Xinrong Geng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.